Legend Biotech (LEGN) Other Non-Current Assets (2020 - 2025)

Legend Biotech's Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $12.4 million for Q4 2025.

• Quarterly Other Non-Current Assets fell 4.62% year-over-year to $12.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (down 4.62% YoY) and the FY2025 annual result came in at $12.4 million, down 4.62% from the prior year.
• Other Non-Current Assets was $12.4 million for Q4 2025 at Legend Biotech, up from $11.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $24.6 million in Q1 2022 and bottomed at $3983.0 in Q1 2021.
• A 5-year average of $5.2 million and a median of $1.8 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 618102.36% — and 2023, when it plunged 95.69%.
• Legend Biotech's Other Non-Current Assets stood at $5.1 million in 2021, then slumped by 71.11% to $1.5 million in 2022, then advanced by 0.4% to $1.5 million in 2023, then surged by 770.73% to $13.0 million in 2024, then slipped by 4.62% to $12.4 million in 2025.
• Business Quant data shows LEGN's Other Non-Current Assets at $12.4 million in Q4 2025, $11.0 million in Q3 2025, and $5.7 million in Q2 2025.